Amy Smith, MD, Pediatric Neuro-Oncologist, joins the Cancer Advances podcast to discuss recent progress in pediatric neuro-oncology. Listen as Dr. Smith explains the advances in tumor biology that are shaping treatment decisions and shares how recent FDA approvals for pediatric low-grade gliomas and diffuse midline gliomas are improving disease control and patient outcomes.

Brian Barnett, MD, Director of the Cleveland Clinic Psychiatric Treatment Resistance Program, joins the Cancer Advances podcast to discuss adjustment disorder in patients with cancer. Dr. Barnett shares how oncologists can better recognize this condition and provides insights on screening and treatment strategies. He also highlights emerging research on psychedelic-assisted therapy that may expand care options for these patients.

Thuy Nguyen, DAOM, LAc, Section Head of Acupuncture for the Wellness ad Preventive Medicine Department at Cleveland Clinic, joins the Cancer Advances podcast discuss how acupuncture is being integrated into cancer care. Listen as she explains the evidence behind using acupuncture for managing treatment-related symptoms, how acupuncture works biologically, key safety considerations and when oncologists should consider referral as part of an integrative oncology approach.

Director of the Inpatient Leukemia Unit, Anjali Advani, MD joins the Cancer Advances podcast to break down the latest acute myeloid leukemia clinical trials. From venetoclax-based regimens to emerging menin inhibitors and mutation-driven strategies, listen as Dr. Advani explains how rapid genomics, novel combinations and evolving transplant decisions are reshaping AML care and what still lies ahead for high-risk disease.

Could removing heat improve safety in endoscopic mucosal resection? Florida Division Chair of the Department of Gastroenterology, Hepatology and Nutrition, and the Florida Region Director for Endoscopy, Tolga Erim, DO, joins the Cancer Advances podcast to break down cold EMR how it compares to traditional EMR, including key differences in bleeding risk, recurrence rates, and clinical trade-offs.

Mina Lobbous, MD, MSPH, Neuro-Oncologist and Medical Director of the Adult Neurofibromatosis and Schwannomatosis Clinic at Cleveland Clinic, joins the Cancer Advances podcast to talk about the landscape of neurofibromatosis and schwannomatosis care. Listen as Dr. Lobbous emphasizes the importance of coordinated pediatric‑to‑adult care, highlighting the emergence of MEK inhibitors and transformational advances in imaging and genomics. 

The Cancer Advances Podcast welcomes back Nathan Mesko, MD, Vice Chair of Global Clinical Operations for the Department of Orthopaedic Surgery and Center Director for Musculoskeletal Oncology at Cleveland Clinic to talk about chemotherapy, limb salvage surgery and how 3D printed custom implants are reshaping outcomes in osteosarcoma. Dr. Mesko also shares a remarkable pediatric case whose complex reconstruction highlights the power of multidisciplinary care, surgical innovation and long term functional recovery.

Bethany Samuelson Bannow, MD, Director of Classical Hematology at Cleveland Clinic, joins the Cancer Advances podcast to discuss the evolving field of classical hematology and what it means for managing complex non-malignant blood diseases. Listen as she covers emerging gene therapies, bispecific antibodies, cancer-associated thrombosis, and practical referral guidance for conditions like ITP, TTP, and sickle cell disease.

Julie Lang, MD, Breast Surgical Oncologist, joins the Cancer Advances podcast to discuss advancing care for patients with inflammatory breast cancer. Listen as Dr. Lang outlines key clinical features that distinguish IBC from infection, evidence-based sequencing of neoadjuvant therapy, surgery and radiation, and highlights emerging tools and translational research efforts aimed at improving outcomes in this aggressive subtype.

Associate Staff and Physician Scientist at Cleveland Clinic Children’s, Richa Sharma, MD, joins the Cancer Advances podcast to discuss the launch of a National DNA Repair and Telomere Biology Disorder Tumor Board. Listen as Dr. Sharma explains the cancer predisposition associated with these rare inherited disorders, the challenges of treating malignancy in patients with impaired DNA repair, and how a multidisciplinary, national tumor board can help clinicians navigate complex treatment decisions and toxicity risks.